O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.82B
AUM Growth
-$649M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
132
New
Increased
Reduced
Closed

Top Buys

1 +$93.6M
2 +$86.8M
3 +$84.8M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$38.9M
5
CYTK icon
Cytokinetics
CYTK
+$38.4M

Top Sells

1 +$81.3M
2 +$55.2M
3 +$48.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$47.5M
5
EVH icon
Evolent Health
EVH
+$47.1M

Sector Composition

1 Healthcare 98.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$401M 8.25%
15,021,721
2
$334M 6.87%
2,718,735
3
$282M 5.81%
3,160,300
-112,700
4
$261M 5.36%
337,600
5
$210M 4.31%
401,700
-32,100
6
$179M 3.68%
7,959,538
7
$128M 2.63%
938,120
+635,900
8
$124M 2.55%
344,400
9
$117M 2.41%
963,400
+8,900
10
$117M 2.4%
189,700
-14,800
11
$113M 2.33%
1,785,571
12
$100M 2.06%
792,000
+10,000
13
$98.5M 2.03%
2,817,347
+492,900
14
$97.8M 2.01%
415,600
+165,300
15
$93.6M 1.93%
+5,693,589
16
$87.4M 1.8%
8,288,510
17
$84.8M 1.74%
+1,145,302
18
$82.6M 1.7%
829,900
-486,100
19
$80.6M 1.66%
3,027,328
20
$77.9M 1.6%
509,100
-303,900
21
$76.2M 1.57%
575,000
22
$74.5M 1.53%
1,584,005
+817,099
23
$70.3M 1.45%
3,812,215
24
$66.2M 1.36%
130,900
-48,100
25
$65.4M 1.34%
413,000
-274,500